4 Nov
2020

Why royalty monetisation transactions are big news for life sciences innovators

For universities, research-based charities and smaller biotechs, selling the rights to drug revenues is an attractive and increasingly common way of generating upfront cash from long-term IP income streams

Richard Gervase

Member

Mintz